On the upside, Colgate-Palmolive Company (NYSE:CL) will test short term resistance at around $66.23. On a downside, the share price is likely to find some support, which begins at $65.58. The failure to get near-term support could push it to $65.21. Its 50 day simple moving average (SMA 50) price is $62.61 and its 200-day simple moving average (SMA 200) price is $64.05. The company’s stock currently has a total float of 863.96M shares. Its weekly volatility is hovering around 1.2% and felt 1.65% volatility in price over a month.
CL stock has been range bound between the range of $65.5 and $65.5 during the whole day. The stock finished Wednesday at $65.94. The -0.12% downtrend forced its market value to reach at $57.29B. The price went up as high as $65.5 before retreating. Trading activity significantly weakened as the volume at ready counter decreased to 3,487,395 shares versus 4,703,515 in average daily trading volume over the past 20 days. So far this year, the volume has averaged about 4,647,146 shares. The stock is now 14.86% above against its bear-market low of $57.41 on October 29, 2018. It has retreated -10.12% since it’s 52-week high of $72.61 reached in April. Now the market price is down -6.05% on the year and up 10.79% YTD.
Separately, it has been reported that multiple insider activity took place at Colgate-Palmolive Company (CL). Director Cahill John T sold 5,780 shares for $42,668 in transaction occurred on 2019/01/31. After making this transaction, the Director owns a direct stake of 372,579 shares, worth $2,813,528, as per the last closing price. On 2018/09/11 Shotts Philip G., Vice President and Controller at CL, dumped 462 shares at an average price of $67.05 per share. The selling total is valued at $5,886,398.
CFO, Jakobsen Henning I had divested 1,015 shares for $42,383 through a trade on 2018/09/11. Following this activity, the insider holds 68,056 shares worth $2,794,735 as of recent close. Wall Street’s most bullish Colgate-Palmolive Company (NYSE:CL) analysts are predicting the share price to blow past $73 per share during the next 12 months. The current median share price forecast by them is $62, suggesting that the stock could increase -5.98% in that time frame. The average price target of $63.52 calls for a nearly -3.67% increase in the stock price.
It had seen a positive analyst call from Exane BNP Paribas, which upgraded the stock from Underperform to Neutral on February 11. Analysts at Evercore ISI, started covering the stock on January 11 with a Outperform rating. The stock won favor of Goldman analysts who expressed their confidence in it using an upgrade from Neutral to Buy on January 09. JP Morgan analysts came out with bearish views on October 29 when the call was made. They think the stock is now Underweight compared to to their prior call for Neutral.
When looking at valuations, Colgate-Palmolive Company (CL) has a cheap P/E of 23.21x as compared to industry average of 74.37x. Moreover, it trades for 21.81 times the next 12 months of expected earnings. Compared to others, Colgate-Palmolive Company is in a different league with regards to profitability, having net margins of 14.2%. To put some perspective around this, the industry’s average net margin is 10.83%. CL’s ROE is -697.6%, which is also considerably worse than the industry’s ROE of 14.75%. It’s also very liquid in the near term, with a current ratio of 1.1. The stock has a debt/capital of 0.
Shares of Colgate-Palmolive Company (CL) have gained 6.1% since the company’s last earnings report. Over the past 12 fiscal quarters, Colgate-Palmolive Company (NYSE:CL) has topped consensus earnings estimates in 4 quarters (33%), missed earnings in 0 quarters (0%), whereas at 8 occasion EPS met analyst expectations. CL last reported earnings on January 25, 2019 when it released Dec-18 results that exceeded expectations. The company raked in $0.74 per share, -20.43% change on the same period last year. That was better than consensus for $0.73. Revenue for the recent quarter stood at $3.81 billion, down -2% on last year and above the $3.77 billion predicted by analysts. For this quarter, Wall Street analysts forecast revenue in a range of $3.82 billion to $3.91 billion, which should be compared with $4.14 billion generated last year. EPS is seen in a range of $0.62 to $0.7, against the $0.8 reported a year ago.